InspireMD, Inc. (NSPR) Financials

NSPR Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 56.5 million 12.9 million
Dec. 31, 2025 69.4 million 14.2 million
Sept. 30, 2025 78.5 million 14.4 million
June 30, 2025 33.3 million 13.1 million

NSPR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -12.5 million ?
Dec. 31, 2025 -9.7 million 2.8 million
Sept. 30, 2025 -9.0 million 3.5 million
June 30, 2025 -8.9 million 3.2 million

NSPR Net Income

No data available :(

NSPR Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 41.6 million - 2.0 million
Dec. 31, 2025 54.2 million - 2.2 million
Sept. 30, 2025 63.4 million - 2.4 million
June 30, 2025 19.4 million - 3.4 million

NSPR Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 73.5 million
Dec. 31, 2025 73.5 million
Sept. 30, 2025 73.5 million
June 30, 2025 51.0 million

NSPR Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 194000 4.8 million 9.9 million 5.2 million
Dec. 31, 2025 398000 3.5 million 9.8 million 5.2 million
Sept. 30, 2025 329000 3.6 million 10.3 million 4.4 million
June 30, 2025 576000 3.8 million 9.5 million 4.2 million

NSPR Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 3.4 million 2.7 million
Dec. 31, 2025 3.1 million 2.0 million
Sept. 30, 2025 2.5 million 1.7 million
June 30, 2025 1.8 million 1.5 million

NSPR Revenue by Segment
Graph available only for paid members. Upgrade to see it.

NSPR

Price: $0.88

52 week price:
0.86
2.93

Earnings Per Share: -0.70 USD

Exchange: NCM

Sector: Healthcare

Industry: Medical Devices

Country: Israel

Volume: 14200

Market Capitalization: 43.3 million

Links: